Background: |
Tumor necrosis factor (TNF; see MIM 191160) receptor-associated factors, such as TRAF7, are signal transducers for members of the TNF receptor superfamily (see MIM 191190). TRAFs are composed of an N-terminal cysteine/histidine-rich region containing zinc RING and/or zinc finger motifs; a coiled-coil (leucine zipper) motif; and a homologous region that defines the TRAF family, the TRAF domain, which is involved in self-association and receptor binding. |
Applications: |
ELISA, WB, IHC |
Name of antibody: |
TRAF7 |
Immunogen: |
Synthetic peptide of human TRAF7 |
Full name: |
TNF receptor-associated factor 7, E3 ubiquitin protein ligase |
Synonyms: |
RFWD1, RNF119 |
SwissProt: |
Q6Q0C0 |
ELISA Recommended dilution: |
1000-5000 |
IHC positive control: |
Human colon cancer and Human gastric cancer |
IHC Recommend dilution: |
15-50 |
WB Predicted band size: |
67 kDa |
WB Positive control: |
Jurkat cells |
WB Recommended dilution: |
200-1000 |